Implantable cardiac devices in the treatment of arrhythmias and congestive heart failure

Soraya Samii, Javier E. Banchs

Research output: Contribution to journalArticle

Abstract

The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalUS Cardiology
Volume9
Issue number1
StatePublished - Feb 2012

Fingerprint

Cardiac Arrhythmias
Heart Failure
Equipment and Supplies
Therapeutics
Cardiac Resynchronization Therapy
Implantable Defibrillators
Standard of Care
Bradycardia
Atrial Fibrillation
Technology

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{4a1d3d14475a493ab9fddf8c02a3a8f2,
title = "Implantable cardiac devices in the treatment of arrhythmias and congestive heart failure",
abstract = "The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.",
author = "Soraya Samii and Banchs, {Javier E.}",
year = "2012",
month = "2",
language = "English (US)",
volume = "9",
pages = "47--52",
journal = "US Cardiology Review",
issn = "1758-3896",
publisher = "Touch Briefings",
number = "1",

}

Implantable cardiac devices in the treatment of arrhythmias and congestive heart failure. / Samii, Soraya; Banchs, Javier E.

In: US Cardiology, Vol. 9, No. 1, 02.2012, p. 47-52.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Implantable cardiac devices in the treatment of arrhythmias and congestive heart failure

AU - Samii, Soraya

AU - Banchs, Javier E.

PY - 2012/2

Y1 - 2012/2

N2 - The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.

AB - The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.

UR - http://www.scopus.com/inward/record.url?scp=84866767606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866767606&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84866767606

VL - 9

SP - 47

EP - 52

JO - US Cardiology Review

JF - US Cardiology Review

SN - 1758-3896

IS - 1

ER -